Histatin 5 Resistance of Candida glabrata Can Be Reversed by Insertion of Candida albicans Polyamine Transporter-Encoding Genes DUR3 and DUR31

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tati, Swetha ^a   Jang, Woong Sik ^a,b   Li, Rui ^a   Kumar, Rohitashw ^a   Puri, Sumant ^a   Edgerton, Mira ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Hoseo University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; HISTATIN 5; ANTIFUNGAL AGENT; FUNGAL PROTEIN; GLUCAN; HISTATIN; HTN3 PROTEIN, HUMAN; SPERMIDINE;

ARTICLE; BINDING AFFINITY; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL SURFACE; CONTROLLED STUDY; DUR3 GENE; DUR31 GENE; FUNGAL CELL; FUNGAL GENE; FUNGAL STRAIN; FUNGUS IMMUNITY; FUNGUS RESISTANCE; GENE INSERTION; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SPECIES COMPARISON; STRAIN DIFFERENCE; UPREGULATION; ANTIFUNGAL RESISTANCE; BIOFILM; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY;

CANDIDA ALBICANS; CANDIDA GLABRATA; FUNGI;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; CANDIDA GLABRATA; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; GLUCANS; HISTATINS; HUMANS; INTRACELLULAR SPACE; MUTAGENESIS, INSERTIONAL; PROTEIN TRANSPORT; SPERMIDINE;

EID: 84876431369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061480     Document Type: Article

References (47)

1. Pfaller MA, Diekema DJ, (2007) Epidemiology of invasive Candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al. (2004) Nosocomial bloodstream infections in US Hospitals: analysis of 24,179 cases from a prospective Nationwide surveillance study. Clin Infect Dis 39: 309-317.
3. Fidel PL, Vazquez JA, Sobel JD, (1999) Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80-96.
4. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, et al. (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 263: 7472-7477.
5. Raj PA, Edgerton M, Levine MJ, (1990) Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem 265: 3898-3905.
6. Raj PA, Marcus E, Sukumaran DK, (1998) Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. Biopolymers 45: 51-67.
7. Xu T, Levitz SM, Diamond RD, Oppenheim FG, (1991) Anticandidal activity of major human salivary histatins. Infect Immun 59: 2549-2554.
8. Tsai H, Bobek LA, (1997) Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans. Biochim Biophys Acta 1336: 367-369.
9. Helmerhorst EJ, Reijnders IM, van't Hof W, Simoons-Smit I, Veerman EC, et al. (1999) Amphotericin B and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Chemother 43: 702-704.
10. Helmerhorst EJ, Venuleo C, Beri A, Oppenheim FG, (2005) Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast 22: 705-714.
11. Konopka K, Dorocka-Bobkowska B, Gebremedhin S, Düzgüneş N, (2010) Susceptibility of Candida biofilms to histatin 5 and fluconazole. Antonie van Leeuwenhoek 97: 413-417.
12. Sanglard D, Ischer F, Calabrese D, Majcherczyk PA, Bille J, (1999) The ATP Binding Cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43: 2753-2765.
13. Sanglard D, Ischer F, Bille J, (2001) Role of ATP-Binding-Cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother 45: 1174-1183.
14. Ferrari SlN, Sanguinetti M, Torelli R, Posteraro B, Sanglard D, (2011) Contribution of CgPDR1 regulated genes in enhanced virulence of azole-resistant Candida glabrata. PLoS ONE 6: e17589.
15. Ferrari SlN, Ischer Fo, Calabrese D, Posteraro B, Sanguinetti M, et al. (2009) Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS Pathog 5: e1000268.
16. Ferrari SlN, Sanguinetti M, De Bernardis F, Torelli R, Posteraro B, et al. (2011) Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother 55: 1852-1860.
17. Seneviratne CJ, Wang Y, Jin L, Abiko Y, Samaranayake LP, (2010) Proteomics of drug resistance in Candida glabrata biofilms. Proteomics 10: 1444-1454.
18. Helmerhorst EJ, Venuleo C, Sanglard D, Oppenheim FG, (2006) Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to Histatin 5. Antimicrob Agents Chemother 50: 1100-1103.
19. Helmerhorst EJ, Troxler RF, Oppenheim FG, (2001) The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc Natl Acad Sci 98: 14637-14642.
20. Koshlukova SE, Lloyd TL, Araujo MWB, Edgerton M, (1999) Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem 274: 18872-18879.
21. Jang WS, Bajwa JS, Sun JN, Edgerton M, (2010) Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans. Mol Microbiol 77: 354-370.
22. Sun JN, Li W, Jang WS, Nayyar N, Sutton MD, et al. (2008) Uptake of the antifungal cationic peptide histatin 5 by Candida albicans Ssa2p requires binding to non-conventional sites within the ATPase domain. Mol Microbiol 70: 1246-1260.
23. Li XS, Sun JN, Okamoto-Shibayama K, Edgerton M, (2006) Candida albicans cell wall Ssa proteins bind and facilitate import of salivary histatin 5 required for toxicity. J Biol Chem 281: 22453-22463.
24. Lowman DW, West LJ, Bearden DW, Wempe MF, Power TD, et al. (2011) New insights into the structure of (1→3,1→6)-β-D-Glucan side chains in the Candida glabrata cell wall. PLoS ONE 6: e27614.
25. Keppler-Ross S, Douglas L, Konopka JB, Dean N, (2010) Recognition of yeast by murine macrophages requires mannan but not glucan. Eukaryot Cell 9: 1776-1787.
26. Taff HT, Nett JE, Zarnowski R, Ross KM, Sanchez H, et al. (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 8: e1002848.
27. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, et al. (2007) Putative role of β-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51: 510-520.
28. Al-Fattani MA, Douglas LJ, (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55: 999-1008.
29. Mochon AB, Liu H, (2008) The antimicrobial peptide Histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Pathog 4: e1000190.
30. Kumar R, Chadha S, Saraswat D, Bajwa JS, Li RA, et al. (2011) Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J Biol Chem 286: 43748-43758.
31. Mayer FoL, Wilson D, Jacobsen ID, Miramón P, Große K, et al. (2012) The novel Candida albicans transporter Dur31 is a multi-stage pathogenicity factor. PLoS Pathog 8: e1002592.
32. Baillie GS, Douglas LJ, (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46: 397-403.
33. Ma B, Pan S-J, Domergue R, Rigby T, Whiteway M, et al. (2009) High-affinity transporters for NAD+precursors in Candida glabrata are regulated by Hst1 and induced in response to niacin limitation. Mol Cell Biol 29: 4067-4079.
34. de Groot PWJ, Kraneveld EA, Yin QY, Dekker HL, Groß U, et al. (2008) The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryt Cell 7: 1951-1964.
35. Sorgo AG, Heilmann CJ, Dekker HL, Brul S, de Koster CG, et al. (2010) Mass spectrometric analysis of the secretome of Candida albicans. Yeast 27: 661-672.
36. Jain N, Kohli R, Cook E, Gialanella P, Chang T, et al. (2007) Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 73: 1697-1703.
37. Lewis RE, Kontoyiannis DP, Darouiche RO, Raad II, Prince RA, (2002) Antifungal activity of amphotericin b, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection. Antimicrob Agents Chemother 46: 3499-3505.
38. Thein ZM, Samaranayake YH, Samaranayake LP, (2007) In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Arch Oral Biol 52: 761-767.
39. Al-Fattani MA, Douglas LJ, (2004) Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 48: 3291-3297.
40. Loureiro y Penha CV, Kubitschek PHB, Larcher G, Perales J, Rodriguez LI, et al. (2010) Proteomic analysis of cytosolic proteins associated with petite mutations in Candida glabrata. Braz J Med Biol Res 43: 1203-1214.
41. Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM, (2006) Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J Antimicrob Chemother 58: 434-438.
42. Ito H, Fukuda Y, Murata K, Kimura A, (1983) Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153: 163-168.
43. Jang WS, Li XS, Sun JN, Edgerton M, (2008) The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding. Antimicrob Agents Chemother 52: 497-504.
44. Fonzi WA, Irwin MY, (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
45. Fidel PL, Cutright LJ Jr, Tait L, Sobel JD, (1996) A murine model of Candida glabrata vaginitis. J Infect Dis 173: 425-431.
46. Cormack BP, Falkow S, (1999) Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 151: 979-987.
47. Joly S, Maze C, McCray PB Jr, Guthmiller JM, (2004) Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42: 1024-1029.